Email

Manchester United star Wilfried Zaha undergoes medical ahead of move to Cardiff City

Wilfried Zaha

The Manchester United player is undergoing a medical today ahead of a move to the Bluebirds for the rest of the season.

Wilfried Zaha

Cardiff City are on the brink of landing Wilfried Zaha, we can reveal.

The £10million Manchester United man is today undergoing a medical ahead of a move to the Welsh capital on loan for the rest of the season.

The Bluebirds’ hopes of capturing their man were boosted after Old Trafford boss David Moyes relented and gave the go-ahead for Zaha to talk to Cardiff.

The mercurial winger, whose brilliance fired Crystal Palace into the Premier League and netted him his move to the reigning champions, was spotted entering hospital to take his medical.

There are still minor issues between the two clubs to be ironed out, but Cardiff are hoping they will be able to formally announce the marquee January signing within days.

Ironically, Cardiff’s next match is away to Manchester United. It is unlikely Moyes will permit Zaha to play in that fixture, but he would be available for the February 1 League clash with Norwich and the games after that.

Moyes rejected a Crystal Palace bid to take Zaha back on loan and was initially reluctant to let the 21-year-old leave for Cardiff while Ashley Young and Nani were injured.

But Young has returned to action, enabling Ole Gunnar Solskjaer to press ahead with his plans to bring in Zaha.

He would be the third Cardiff capture in this month’s transfer window, Solskjaer having already netted Norwegians Magnus Wolff Eikrem and Mats Moller Daehli.

Solskjaer is hoping Zaha’s creative brilliance can help get his Bluebirds off the bottom of the table and flying again in the Premier League.

Related posts

Vikings waive former starting cornerback Akayleb Evans in another blow to 2022 draft class

Ronaldo’s Al-Nassr eyes Asian glory amid revitalised Saudi Pro League campaign

Nigeria’s terror group Lakurawa is nothing new – it exists because of government’s failure: analysts